
Global & Spain Interventional Cardiology Devices Market to 2033
Description
Spain is a key market for interventional cardiology devices in Europe, distinguished by its universal healthcare system, high life expectancy, and a significant prevalence of cardiovascular diseases (CVDs). Although the age-standardized mortality rates for CVD are lower than in some other European countries, the overall number of cases and the healthcare costs associated with them pose considerable challenges, particularly due to an aging demographic.
CVD is the primary cause of mortality in Spain, with 119,196 deaths recorded in 2021 due to these conditions. There is a notable prevalence of cardiovascular risk factors, including dyslipidemia, a lack of physical activity, and hypertension. Interventional cardiology procedures are commonly conducted within the Spanish National Health System (SNS). The European Society of Cardiology reported that in 2022, Spain had 1,572.9 percutaneous coronary interventions (PCI) per million inhabitants. Although Spain has historically had lower rates of primary PCI compared to some European countries, there has been a noticeable increase in PCI procedures over the years, reflecting a growing acceptance of these treatments.
Despite variations in healthcare resources across regions, the overall healthcare infrastructure in Spain supports high-quality procedural standards. Cost-containment measures impact device procurement, prioritizing those that are both effective and economical. The market remains stable, with gradual growth fueled by advancements in technology and rising demand for procedures.
CVD is the primary cause of mortality in Spain, with 119,196 deaths recorded in 2021 due to these conditions. There is a notable prevalence of cardiovascular risk factors, including dyslipidemia, a lack of physical activity, and hypertension. Interventional cardiology procedures are commonly conducted within the Spanish National Health System (SNS). The European Society of Cardiology reported that in 2022, Spain had 1,572.9 percutaneous coronary interventions (PCI) per million inhabitants. Although Spain has historically had lower rates of primary PCI compared to some European countries, there has been a noticeable increase in PCI procedures over the years, reflecting a growing acceptance of these treatments.
Despite variations in healthcare resources across regions, the overall healthcare infrastructure in Spain supports high-quality procedural standards. Cost-containment measures impact device procurement, prioritizing those that are both effective and economical. The market remains stable, with gradual growth fueled by advancements in technology and rising demand for procedures.
Table of Contents
122 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Spain Interventional Cardiology Devices Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Interventional Cardiology Devices Market Key Market Dynamics
- 5.1 Interventional Cardiology Devices Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Spain Interventional Cardiology Devices Market – Analysis
- 6.1 Spain Interventional Cardiology Devices Market Revenue (US$ Million), 2022–2033
- 6.2 Spain Interventional Cardiology Devices Market Revenue and Forecast Analysis
- 7. Spain Interventional Cardiology Devices Market Analysis – by Product Type
- 7.1 Spain Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Product Type
- 8. Spain Interventional Cardiology Devices Market Analysis – by Material Type
- 8.1 Spain Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Material Type
- 9. Spain Interventional Cardiology Devices Market Analysis – by Application
- 9.1 Spain Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Application
- 10. Spain Interventional Cardiology Devices Market Analysis – by Indication
- 10.1 Spain Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Indication
- 11. Spain Interventional Cardiology Devices Market Analysis – by End User
- 11.1 Spain Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by End User
- 12. Competitive Landscape
- 12.1Heat Map Analysis by Key Players
- 12.1Company Positioning and Concentration
- 13. Industry Landscape
- 13.1Overview
- 13.2Market Initiative
- 13.2Partnerships and Collaborations
- 13.2Other Developments
- 14. Company Profiles
- 14.1 Medtronic Plc
- 14.1. 1 Key Facts
- 14.1. 2 Business Description
- 14.1. 3 Products and Services
- 14.1. 4 Financial Overview
- 14.1. 5 SWOT Analysis
- 14.1. 6 Key Developments
- 14.2 Boston Scientific Corp
- 14.2. 1 Key Facts
- 14.2. 2 Business Description
- 14.2. 3 Products and Services
- 14.2. 4 Financial Overview
- 14.2. 5 SWOT Analysis
- 14.2. 6 Key Developments
- 14.3 Abbott Laboratories
- 14.3. 1 Key Facts
- 14.3. 2 Business Description
- 14.3. 3 Products and Services
- 14.3. 4 Financial Overview
- 14.3. 5 SWOT Analysis
- 14.3. 6 Key Developments
- 14.4 B Braun SE
- 14.4. 1 Key Facts
- 14.4. 2 Business Description
- 14.4. 3 Products and Services
- 14.4. 4 Financial Overview
- 14.4. 5 SWOT Analysis
- 14.4. 6 Key Developments
- 14.5 Terumo Corp
- 14.5. 1 Key Facts
- 14.5. 2 Business Description
- 14.5. 3 Products and Services
- 14.5. 4 Financial Overview
- 14.5. 5 SWOT Analysis
- 14.5. 6 Key Developments
- 14.6 Edwards Lifesciences Corp
- 14.6. 1 Key Facts
- 14.6. 2 Business Description
- 14.6. 3 Products and Services
- 14.6. 4 Financial Overview
- 14.6. 5 SWOT Analysis
- 14.6. 6 Key Developments
- 14.7 Teleflex Inc
- 14.7. 1 Key Facts
- 14.7. 2 Business Description
- 14.7. 3 Products and Services
- 14.7. 4 Financial Overview
- 14.7. 5 SWOT Analysis
- 14.7. 6 Key Developments
- 14.8 Lepu Medical Technology Beijing Co Ltd
- 14.8. 1 Key Facts
- 14.8. 2 Business Description
- 14.8. 3 Products and Services
- 14.8. 4 Financial Overview
- 14.8. 5 SWOT Analysis
- 14.8. 6 Key Developments
- 14.9 W L Gore and Associates Inc
- 14.9. 1 Key Facts
- 14.9. 2 Business Description
- 14.9. 3 Products and Services
- 14.9. 4 Financial Overview
- 14.9. 5 SWOT Analysis
- 14.9. 6 Key Developments
- 14.10 Meril Life Sciences Pvt Ltd
- 14.10. 1 Key Facts
- 14.10. 2 Business Description
- 14.10. 3 Products and Services
- 14.10. 4 Financial Overview
- 14.10. 5 SWOT Analysis
- 14.10. 6 Key Developments
- 15. Appendix
- 15.1 About Business Market Insights
- 15.2 List of Abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.